C

CNS Healthcare | Clinical Neuroscience Solutions - Memphis

Research site

(Unclaimed)

Location

6401 Poplar Avenue, Suite 420, Memphis, Tennessee, United States of America

Site insights

Top conditions

Top treatments

Cariprazine

Testosterone

SPN-812

AD109

TNX-601

BOTOX

Eptinezumab

Risankizumab

Sildenafil

Atogepant

Parent organization

This site is a part of CNS Healthcare

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 12 total trials

A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease (FORTIFY)

The study consists of 4 sub-studies, as follows:* Sub-study 1 (Randomized, double-blind, placebo controlled study) to evaluate the efficacy and safet...

Active, not recruiting

Crohn's Disease

Drug: Placebo for Risankizumab IV

Drug: Risankizumab SC

Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule)

Open label extension, long-term multicenter study of safety and efficacy of SPN-812 in pediatric ADHD patients

Active, not recruiting

Attention-Deficit/Hyperactivity Disorder

Drug: SPN-812

Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)

This is a Phase 3 Randomized Double-Blind Placebo-Controlled 1-year Parallel-Arm Study to Compare a Fixed Dose Combination of AD109 to Placebo in Obs...

Active, not recruiting

OSA

Drug: Placebo

Drug: AD109

Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine

Migraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and so...

Active, not recruiting

Episodic Migraine

Drug: Placebo

Drug: BOTOX